V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250011997 | 250010914 | 1.77 | 91.2 | Palliative (P) | 2014-09-13 | 2014-10-29 | Cytarabine Low Dose | N | N | 250031258 | CISPLATIN + PACLITAXEL |
| 250011998 | 250007828 | null | null | Not known (9) | 2013-03-29 | 2013-03-29 | PEMBROLIZUMAB | null | null | 250031269 | AZACITIDINE |
| 250011999 | 250007834 | null | 67.65 | Palliative (P) | 2015-03-17 | 2015-03-30 | Cytarabine High Dose | N | null | 250031279 | CARBOPLATIN + VINORELBINE |
| 250012001 | 250007839 | 1.69 | null | Palliative (P) | 2016-01-14 | 2016-01-14 | CHOP R - 21 days | N | null | 250031299 | CARBOPLATIN + VINORELBINE |
| 250012002 | 250010918 | 1.7 | 177.2 | Palliative (P) | 2017-12-04 | 2018-04-24 | Pemetrexed | N | N | 250031300 | GEMCARBO |
| 250012003 | 250007844 | 1.65 | 77.45 | Neo-adjuvant (N) | 2017-05-13 | 2017-06-07 | AML Interim Guidelines FLAG-Ida | 2 | N | 250031323 | PILOT TRIAL |
| 250012004 | 250007848 | 1.82 | 91.799 | Palliative (P) | 2014-01-25 | 2014-02-02 | BUSULFAN | null | N | 250031327 | GEMCARBO |
| 250012005 | 250012595 | 1.63 | null | Not known (9) | 2018-04-16 | 2018-04-16 | NAB PACLITAXEL | null | null | 250031349 | GEMCARBO |
| 250012006 | 250007851 | 1.77 | 74.9 | Palliative (P) | 2017-01-01 | 2017-01-02 | Docetaxel | 02 | N | 250031377 | GEMCARBO |
| 250012007 | 250007857 | 1.62 | 65 | Palliative (P) | 2017-11-18 | 2017-11-19 | CARBOPLATIN + PACLITAXEL | N | N | 250031416 | ABIRATERONE |
| 250012008 | 250007858 | 1.6 | 0 | Palliative (P) | 2018-02-26 | 2018-03-09 | Azacitidine | 02 | N | 250031419 | PEMBROLIZUMAB |
| 250012009 | 250010925 | 1.65 | 72 | Not known (9) | 2015-08-07 | 2015-11-19 | IMATINIB | N | null | 250031419 | ATG + BUSULFAN + FLUDARABINE |
| 250012010 | 250010926 | 1.72 | 64 | Palliative (P) | 2016-07-30 | 2016-08-27 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 250031451 | CARBOPLATIN + VINORELBINE |
| 250012011 | 250007862 | null | 69 | Palliative (P) | 2015-07-04 | 2015-07-12 | THALIDOMIDE | 02 | Y | 250031485 | METHOTREXATE INTRATHECAL |
| 250012012 | 250007863 | 1.6 | 95.5 | Palliative (P) | 2017-02-17 | 2017-02-18 | CARBOPLATIN + GEMCITABINE | N | N | 250031488 | GEMCARBO |
| 250012013 | 250007864 | null | 67.8 | Neo-adjuvant (N) | 2016-02-03 | 2016-07-10 | Azacitidine | 02 | N | 250031490 | IPM |
| 250012014 | 250007870 | 1.66 | 50.5 | Disease modification (D) | 2016-03-24 | 2016-06-11 | FLAG + Idarubicin | 01 | N | 250031520 | GEMCARBO |
| 250012015 | 250007873 | 1.67 | 73 | Disease modification (D) | 2013-10-09 | 2014-01-29 | GEMCARBO | 2 | N | 250031522 | IPM |
| 250012016 | 250007875 | 1.91 | null | Palliative (P) | 2018-01-04 | 2018-01-06 | Rituximab | 02 | N | 250031530 | GEMCARBO |
| 250012017 | 250007877 | null | null | Disease modification (D) | 2014-03-24 | 2014-03-24 | Docetaxel | N | null | 250031552 | BORTEZOMIB |
| 250012018 | 250007878 | 1.65 | null | Palliative (P) | 2015-12-02 | 2015-12-02 | BORTEZOMIB + THALIDOMIDE | N | null | 250031571 | PEMETREXED |
| 250012019 | 250007880 | null | null | Adjuvant (A) | 2017-10-07 | 2017-10-24 | GemCarbo Days 1+8 | N | N | 250031619 | NOT MATCHED |
| 250012020 | 250007881 | 1.64 | 91.9 | Curative (C) | 2018-01-17 | 2018-01-17 | Pemetrexed | 02 | N | 250031622 | AZACITIDINE |
| 250012021 | 250007882 | null | null | Curative (C) | 2016-04-03 | 2016-07-18 | IPM | N | N | 250031624 | NOT MATCHED |
| 250012022 | 250007884 | null | null | Disease modification (D) | null | 2018-07-20 | CHOP R - 21 days | N | N | 250031634 | CARBOPLATIN |
| 250012023 | 250007884 | 1.75 | 59 | Palliative (P) | 2015-11-10 | 2015-11-10 | IPM | N | N | 250031634 | CARBOPLATIN + PACLITAXEL |
| 250012024 | 250012132 | 1.59 | 65.4 | Palliative (P) | 2018-12-15 | 2018-12-22 | Pemetrexed | 02 | N | 250031668 | GEMCARBO |
| 250012025 | 250007888 | null | 79.9 | Curative (C) | null | 2015-09-10 | GemCarbo Days 1+8 | 02 | N | 250031685 | FLAG + IDARUBICIN |
| 250012026 | 250007890 | null | 38.1 | Palliative (P) | 2015-03-06 | 2015-03-20 | AML18 PILOT TRIAL | N | N | 250031702 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 250012027 | 250007896 | 1.75 | 67.7 | Palliative (P) | 2015-09-25 | 2015-10-03 | Pemetrexed | N | N | 250031746 | ERIBULIN |
| 250012028 | 250007899 | null | 32.8 | Palliative (P) | 2018-05-01 | 2018-06-01 | BUSULFAN | N | N | 250031753 | CYCLOPHOSPHAMIDE |
| 250012029 | 250007901 | 1.83 | 62.5 | Palliative (P) | 2016-11-21 | 2016-12-17 | Carboplatin + Vinorelbine Oral | N | N | 250031764 | PEMETREXED |
| 250012030 | 250007904 | null | 69.6 | Palliative (P) | 2018-12-18 | 2018-12-18 | Methotrexate intrathecal | null | N | 250031801 | DA |
| 250012031 | 250010945 | 1.77 | 59.5 | Disease modification (D) | 2015-04-16 | 2015-04-16 | CARBOPLATIN | 2 | N | 250031814 | GEMCARBO |
| 250012032 | 250007905 | null | null | null | 2014-04-16 | 2014-04-20 | GemCarbo Days 1+8 | Y | N | 250031817 | CAPECITABINE |
| 250012033 | 250007906 | 1.72 | null | Palliative (P) | 2016-04-25 | 2017-12-03 | GemCarbo Days 1+8 | Y | null | 250031821 | RITUXIMAB |
| 250012034 | 250007908 | 1.68 | 65.1 | Palliative (P) | 2016-04-03 | 2016-04-04 | COMMAND trial | N | N | 250031848 | LIPOSOMAL DOXORUBICIN |
| 250012035 | 250007910 | null | 48.5 | Curative (C) | 2018-02-19 | 2018-02-19 | FLUOROURACIL + IRINOTECAN | 2 | N | 250031855 | DOCETAXEL |
| 250012036 | 250007912 | null | 66.2 | Curative (C) | 2013-10-04 | 2013-12-29 | FLUDARABINE + MELPHALAN | N | null | 250031866 | BENDAMUSTINE + RITUXIMAB |
| 250012037 | 250007915 | 1.56 | null | Curative (C) | 2014-05-27 | 2014-08-31 | Rituximab (Maintenance) | null | N | 250031889 | GEMCARBO |
| 250012038 | 250010951 | 1.78 | null | Disease modification (D) | null | 2019-01-10 | Bevacizumab 7.5mg/kg | null | N | 250031907 | NOT MATCHED |
| 250012040 | 250007920 | 1.68 | 38.3 | Disease modification (D) | 2014-10-04 | 2015-08-26 | Imatinib 400mg | N | null | 250031917 | GEMCARBO |
| 250012041 | 250010954 | null | 48.5 | Curative (C) | 2015-06-29 | 2015-07-03 | Cytarabine High Dose | 02 | N | 250031931 | IPM |
| 250012042 | 250010955 | 1.59 | null | Curative (C) | 2016-07-28 | 2016-07-28 | NAB PACLITAXEL | null | N | 250031935 | AZACITIDINE |
| 250012043 | 250007926 | 1.81 | 69 | Curative (C) | 2014-12-27 | 2015-01-15 | Carboplatin + Paclitaxel (3 weekly) | N | N | 250031948 | GEMCARBO |
| 250012045 | 250007930 | 1.67 | 64.5 | Disease modification (D) | 2018-12-12 | 2018-12-12 | Carboplatin AUC 6 - 10 | null | N | 250031957 | PEMBROLIZUMAB |
| 250012046 | 250012141 | null | null | Palliative (P) | null | 2014-10-02 | IPM | N | Y | 250031960 | CARBOPLATIN |
| 250012047 | 250007931 | null | 77.45 | Palliative (P) | 2011-04-26 | 2015-02-28 | CISPLATIN + Ganetespib + Ganetespib + PEMETREXED | N | N | 250031978 | CISPLATIN + GEMCITABINE |
| 250012048 | 250010960 | 1.52 | 82 | Palliative (P) | 2017-12-28 | 2017-12-28 | Cytarabine High Dose | 01 | N | 250031985 | IPM |
| 250012049 | 250007934 | 1.56 | 177.2 | Palliative (P) | null | 2014-10-16 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 250031988 | CARBOPLATIN + VINORELBINE |